133 related articles for article (PubMed ID: 20938011)
1. Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alfa-2b.
Skippen B; Tsang HH; Assaad NN; Coroneo MT
Arch Ophthalmol; 2010 Oct; 128(10):1368-9. PubMed ID: 20938011
[No Abstract] [Full Text] [Related]
2. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
Krilis M; Tsang H; Coroneo M
Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
[TBL] [Abstract][Full Text] [Related]
3. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
Dudney BW; Malecha MA
Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170
[TBL] [Abstract][Full Text] [Related]
4. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
6. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
Vann RR; Karp CL
Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
[TBL] [Abstract][Full Text] [Related]
7. Treatment of partial limbal stem cell deficiency with topical interferon α-2b and retinoic acid.
Tan JC; Tat LT; Coroneo MT
Br J Ophthalmol; 2016 Jul; 100(7):944-948. PubMed ID: 26508779
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with 5-Fu.
Schechter BA; Nagler RS
Ophthalmology; 2003 Jun; 110(6):1262-3; author reply 1263. PubMed ID: 12799258
[No Abstract] [Full Text] [Related]
9. Successful treatment with 5-Fu.
Schechter BA; Nagler RS
Ophthalmology; 2003 Apr; 110(4):625-6; author reply 626. PubMed ID: 12689863
[No Abstract] [Full Text] [Related]
10. Treatment of CIN with retinoic acid and topical interferon alfa-2b.
Huerva V
Ophthalmology; 2013 Aug; 120(8):e55. PubMed ID: 23916085
[No Abstract] [Full Text] [Related]
11. Topical medical therapies for ocular surface tumors.
Poothullil AM; Colby KA
Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
Schechter BA; Koreishi AF; Karp CL; Feuer W
Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
[TBL] [Abstract][Full Text] [Related]
13. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
Holcombe DJ; Lee GA
Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
[TBL] [Abstract][Full Text] [Related]
14. Use of topical retinoic acid for limbal stem cell failure: a retrospective clinical case series.
Chew SK; Watson S
Clin Exp Ophthalmol; 2016 Apr; 44(3):217-8. PubMed ID: 26433208
[No Abstract] [Full Text] [Related]
15. Mitomycin C therapy for corneal intraepithelial neoplasia masquerading as limbal stem cell deficiency with recurrent epithelial defect.
Gokhale NS
Int Ophthalmol; 2011 Apr; 31(2):161-3. PubMed ID: 21327677
[TBL] [Abstract][Full Text] [Related]
16. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Wilson MW; Hungerford JL; George SM; Madreperla SA
Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
[TBL] [Abstract][Full Text] [Related]
17. Recurrent intraepithelial neoplasia treatment.
Schechter BA; Nagler RS; Schrier A
Ophthalmology; 2005 Jul; 112(7):1319; author reply 1319. PubMed ID: 15993243
[No Abstract] [Full Text] [Related]
18. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Sinha B; Kumar R
Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
[TBL] [Abstract][Full Text] [Related]
20. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
Haas K; Ben-Dor D; Levartovsky S
Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591
[No Abstract] [Full Text] [Related]
[Next] [New Search]
